{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:58:33Z","timestamp":1790312313308,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["232300421044"],"award-info":[{"award-number":["232300421044"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004773","name":"Henan University","doi-asserted-by":"publisher","award":["202110475084"],"award-info":[{"award-number":["202110475084"]}],"id":[{"id":"10.13039\/501100004773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004773","name":"Henan University","doi-asserted-by":"publisher","award":["20217003001"],"award-info":[{"award-number":["20217003001"]}],"id":[{"id":"10.13039\/501100004773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018551","name":"Science and Technology Innovation Talents in Universities of Henan Province","doi-asserted-by":"publisher","award":["25IRTSTHN032"],"award-info":[{"award-number":["25IRTSTHN032"]}],"id":[{"id":"10.13039\/501100018551","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52373133"],"award-info":[{"award-number":["52373133"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.biomaterials.2026.124527","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:24:25Z","timestamp":1785799465000},"page":"124527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Polyphosphorylcholine-modified liposomes for glioblastoma-targeted siRNA delivery across the blood-brain barrier"],"prefix":"10.1016","volume":"337","author":[{"given":"Muhammad","family":"Ismail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yundong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjiang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.biomaterials.2026.124527_bib1","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2026.124527_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.addr.2020.07.022","article-title":"Recent advances in siRNA delivery mediated by lipid-based nanoparticles","volume":"154\u2013155","author":"Yonezawa","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2026.124527_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124527_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal formulations in clinical use: an updated review","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124527_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-023-01668-1","article-title":"Multifunctional nanoparticle-mediated combining therapy for human diseases","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124527_bib6","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/s41565-024-01769-0","article-title":"Polymer-locking fusogenic liposomes for glioblastoma-targeted siRNA delivery and CRISPR\u2013Cas gene editing","volume":"19","author":"Zhao","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2026.124527_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121608","article-title":"Targeted liposomes for combined delivery of artesunate and temozolomide to resistant glioblastoma","volume":"287","author":"Ismail","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124527_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jconrel.2024.06.005","article-title":"PEG length effect of peptide-functional liposome for blood-brain barrier (BBB) penetration and brain targeting","volume":"372","author":"Du","year":"2024","journal-title":"J. Contr. Release"},{"issue":"19","key":"10.1016\/j.biomaterials.2026.124527_bib9","article-title":"Abstract CT216: phase I dose escalating study of 2B3-101, glutathione PEGylated liposomal doxorubicin, in patients with solid tumors and brain metastases or recurrent malignant glioma","volume":"74","author":"Gaillard","year":"2014","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124527_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100365","article-title":"Targeting immunoliposomes to EGFR-positive glioblastoma","volume":"7","author":"Kasenda","year":"2022","journal-title":"ESMO Open"},{"issue":"2\u20134","key":"10.1016\/j.biomaterials.2026.124527_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1515\/ejnm-2012-0010","article-title":"Limitations and niches of the active targeting approach for nanoparticle drug delivery","volume":"4","author":"Chen","year":"2012","journal-title":"Eur. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2026.124527_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2018.02.040","article-title":"Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: challenges and opportunities","volume":"277","author":"Belfiore","year":"2018","journal-title":"J. Contr. Release"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124527_bib13","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1021\/acsnano.1c05922","article-title":"Polyethylene glycol immunogenicity: theoretical, clinical, and practical aspects of anti-polyethylene glycol antibodies","volume":"15","author":"Chen","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124527_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154","author":"Kozma","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"40","key":"10.1016\/j.biomaterials.2026.124527_bib15","doi-asserted-by":"crossref","first-page":"18419","DOI":"10.1021\/jacs.2c06877","article-title":"Engineering poly (ethylene glycol) nanoparticles for accelerated blood clearance inhibition and targeted drug delivery","volume":"144","author":"Tian","year":"2022","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124527_bib16","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1080\/14686996.2019.1627174","article-title":"PEGylated liposomes: immunological responses","volume":"20","author":"Mohamed","year":"2019","journal-title":"Sci. Technol. Adv. Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124527_bib17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41565-018-0344-3","article-title":"Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles","volume":"14","author":"Vu","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124527_bib18","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41401-023-01169-5","article-title":"Reexamining the effects of drug loading on the in vivo performance of PEGylated liposomal doxorubicin","volume":"45","author":"Yu","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2026.124527_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpharm.2014.09.047","article-title":"Influence of dose and animal species on accelerated blood clearance of PEGylated liposomal doxorubicin","volume":"476","author":"Suzuki","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124527_bib20","doi-asserted-by":"crossref","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","article-title":"Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine","volume":"16","author":"Ju","year":"2022","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124527_bib21","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1021\/bm701301s","article-title":"Zwitterionic polymers exhibiting high resistance to nonspecific protein adsorption from human serum and plasma","volume":"9","author":"Ladd","year":"2008","journal-title":"Biomacromolecules"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124527_bib22","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.1021\/acsnano.7b01110","article-title":"Zwitterionic nanocarrier surface chemistry improves siRNA tumor delivery and silencing activity relative to polyethylene glycol","volume":"11","author":"Jackson","year":"2017","journal-title":"ACS Nano"},{"issue":"18","key":"10.1016\/j.biomaterials.2026.124527_bib23","article-title":"A bioinspired platform for effective delivery of protein therapeutics to the central nervous system","volume":"31","author":"Wu","year":"2019","journal-title":"Adv. Mater."},{"issue":"19","key":"10.1016\/j.biomaterials.2026.124527_bib24","article-title":"Systemic delivery of monoclonal antibodies to the central nervous system for brain tumor therapy","volume":"31","author":"Han","year":"2019","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124527_bib25","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1021\/acsnano.1c08120","article-title":"Smart nanomedicine to enable crossing blood\u2013brain barrier delivery of checkpoint blockade antibody for immunotherapy of glioma","volume":"16","author":"Wang","year":"2022","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124527_bib26","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41551-019-0434-z","article-title":"Sustained delivery and molecular targeting of a therapeutic monoclonal antibody to metastases in the central nervous system of mice","volume":"3","author":"Wen","year":"2019","journal-title":"Nat. Biomed. Eng."},{"issue":"39","key":"10.1016\/j.biomaterials.2026.124527_bib27","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1002\/adma.201101899","article-title":"Choline\u2010derivate\u2010modified nanoparticles for brain\u2010targeting gene delivery","volume":"23","author":"Li","year":"2011","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124527_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000207","article-title":"Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery","volume":"8","author":"Zheng","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"16","key":"10.1016\/j.biomaterials.2026.124527_bib29","doi-asserted-by":"crossref","first-page":"eabm8011","DOI":"10.1126\/sciadv.abm8011","article-title":"Blood-brain barrier-penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy","volume":"8","author":"Zou","year":"2022","journal-title":"Sci. Adv."},{"issue":"9\u201010","key":"10.1016\/j.biomaterials.2026.124527_bib30","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/smll.201201390","article-title":"Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking","volume":"9","author":"Duan","year":"2013","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2026.124527_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2020.127359","article-title":"Hypoxia-degradable zwitterionic phosphorylcholine drug nanogel for enhanced drug delivery to glioblastoma","volume":"408","author":"She","year":"2021","journal-title":"Chem. Eng. J."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124527_bib32","doi-asserted-by":"crossref","first-page":"583","DOI":"10.7150\/thno.11234","article-title":"Zwitterionic poly (carboxybetaine)-based cationic liposomes for effective delivery of small interfering RNA therapeutics without accelerated blood clearance phenomenon","volume":"5","author":"Li","year":"2015","journal-title":"Theranostics"},{"issue":"20","key":"10.1016\/j.biomaterials.2026.124527_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202301777","article-title":"Interplay between liposomes and IgM: principles, challenges, and opportunities","volume":"10","author":"Wang","year":"2023","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124527_bib34","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1038\/s41467-024-50568-7","article-title":"Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin","volume":"15","author":"Jiang","year":"2024","journal-title":"Nat. Commun."},{"issue":"33","key":"10.1016\/j.biomaterials.2026.124527_bib35","article-title":"Efficient delivery of nerve growth factors to the central nervous system for neural regeneration","volume":"31","author":"Xu","year":"2019","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124527_bib36","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41551-024-01250-2","article-title":"Meta-analysis of the make-up and properties of in vitro models of the healthy and diseased blood\u2013brain barrier","volume":"9","author":"Shamul","year":"2025","journal-title":"Nat. Biomed. Eng."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124527_bib37","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.bbrc.2020.09.008","article-title":"Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC","volume":"533","author":"Wang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"24","key":"10.1016\/j.biomaterials.2026.124527_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202000416","article-title":"Single siRNA nanocapsules for effective siRNA brain delivery and glioblastoma treatment","volume":"32","author":"Zou","year":"2020","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124527_bib39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/neuonc\/noaa259","article-title":"The evolution of the cancer stem cell state in glioblastoma: emerging insights into the next generation of functional interactions","volume":"23","author":"Lathia","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.biomaterials.2026.124527_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.615704","article-title":"Glioma stem cells as immunotherapeutic targets: advancements and challenges","volume":"11","author":"Piper","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124527_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115759","article-title":"Overcoming barriers and shaping the future: challenges and innovations in nucleic acid therapies for Glioblastoma","volume":"229","author":"Zam","year":"2026","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"51","key":"10.1016\/j.biomaterials.2026.124527_bib42","article-title":"Brain-targeted liposomes loaded with monoclonal antibodies reduce alpha-Synuclein aggregation and improve behavioral symptoms in Parkinson's disease","volume":"35","author":"Sela","year":"2023","journal-title":"Adv. Mater."},{"issue":"41","key":"10.1016\/j.biomaterials.2026.124527_bib43","doi-asserted-by":"crossref","first-page":"36106","DOI":"10.1021\/acsnano.4c15013","article-title":"AI-validated brain targeted mRNA lipid nanoparticles with neuronal tropism","volume":"19","author":"Sela","year":"2025","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124527_bib44","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/17425247.2021.1873273","article-title":"Towards precision nanomedicine for cerebrovascular diseases with emphasis on Cerebral Cavernous Malformation (CCM)","volume":"18","author":"Perrelli","year":"2021","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biomaterials.2026.124527_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110770","article-title":"PEGylated nanocarriers: a promising tool for targeted delivery to the brain","volume":"187","author":"Gajbhiye","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biomaterials.2026.124527_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102163","article-title":"Anti-PEG antibodies: current situation and countermeasures","volume":"55","author":"Fu","year":"2024","journal-title":"Nano Today"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124527_bib47","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0022-3565(24)35391-1","article-title":"Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes","volume":"292","author":"Dams","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"32","key":"10.1016\/j.biomaterials.2026.124527_bib48","doi-asserted-by":"crossref","first-page":"9625","DOI":"10.1021\/la500057j","article-title":"Zwitteration: coating surfaces with zwitterionic functionality to reduce nonspecific adsorption","volume":"30","author":"Schlenoff","year":"2014","journal-title":"Langmuir"},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124527_bib49","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/cancers9100131","article-title":"The emerging role of polo-like kinase 1 in epithelial-mesenchymal transition and tumor metastasis","volume":"9","author":"Fu","year":"2017","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124527_bib50","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nm.4364","article-title":"Plk1 regulates contraction of postmitotic smooth muscle cells and is required for vascular homeostasis","volume":"23","author":"de C\u00e1rcer","year":"2017","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124527_bib51","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/cgt.2013.46","article-title":"Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell death in glioblastoma","volume":"20","author":"Pezuk","year":"2013","journal-title":"Cancer Gene Ther."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124527_bib52","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.acthis.2011.09.004","article-title":"Clinicopathological significance of Polo-like kinase 1 (PLK1) expression in human malignant glioma","volume":"114","author":"Cheng","year":"2012","journal-title":"Acta Histochem."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124527_bib53","doi-asserted-by":"crossref","first-page":"eaau7566","DOI":"10.1126\/sciadv.aau7566","article-title":"A methylation-phosphorylation switch determines Plk1 kinase activity and function in DNA damage repair","volume":"5","author":"Li","year":"2019","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124527_bib54","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41420-023-01302-7","article-title":"PLK1 inhibition promotes apoptosis and DNA damage in glioma stem cells by regulating the nuclear translocation of YBX1","volume":"9","author":"Li","year":"2023","journal-title":"Cell Death Discov."},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124527_bib55","doi-asserted-by":"crossref","first-page":"10133","DOI":"10.1021\/acs.jmedchem.2c00614","article-title":"Polo-like kinase 1 inhibitors in human cancer therapy: development and therapeutic potential","volume":"65","author":"Zhang","year":"2022","journal-title":"J. Med. Chem."},{"issue":"45","key":"10.1016\/j.biomaterials.2026.124527_bib56","article-title":"Cation-free siRNA micelles as effective drug delivery platform and potent RNAi nanomedicines for glioblastoma therapy","volume":"33","author":"Jiang","year":"2021","journal-title":"Adv. Mater."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124527_bib57","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/s41588-025-02167-5","article-title":"The multilayered transcriptional architecture of glioblastoma ecosystems","volume":"57","author":"Nomura","year":"2025","journal-title":"Nat. Genet."},{"issue":"27","key":"10.1016\/j.biomaterials.2026.124527_bib58","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1038\/s41388-023-02738-y","article-title":"Glioblastoma heterogeneity at single cell resolution","volume":"42","author":"Eisenbarth","year":"2023","journal-title":"Oncogene"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296122600551X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296122600551X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:59:17Z","timestamp":1790308757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014296122600551X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":58,"alternative-id":["S014296122600551X"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124527","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyphosphorylcholine-modified liposomes for glioblastoma-targeted siRNA delivery across the blood-brain barrier","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"124527"}}